Eli Lilly (NYSE:LLY | LLY Price Prediction) delivered a monster quarter with revenue growth, a fourt

This market has a population of almost 60 million. While the drug isn't the first of its type to be

Year to date, the healthcare sector finds itself in the middle of the S&P 500's pack.

Investors are still skittish enough that they only want to buy proven winners, so backing the favori

Eli Lilly and Company NYSE: LLY reported 48% revenue growth in the second quarter of 2026, driven pr

Eli Lilly should request approval for retatrutide early next year. This medicine could help the comp

Eli Lilly and Company delivered a monumental Q2 2026, with revenues up 48% to $23 billion, driven by

The ETF market saw a massive surge into core index heavyweights this past week, as investors poured

Jim Cramer praises Lockheed Martin and Ameriprise Financial, advises against Cipher Digital. Eli Lil

Amazon Pharmacy offers eligible Medicare patients weight-loss drugs for $50 monthly under a new fede

Eli Lilly's latest results made investors happy, as the stock jumped 5% on their release, as both re

Eli Lilly (NYSE:LLY | LLY Price Prediction) just delivered one of the cleanest beat-and-raise quarte

Lilly lifts its 2026 outlook as Foundayo adoption accelerates, Medicare expands obesity access and r

A Dutch court has banned sales of an unapproved compounded semaglutide nasal spray following a legal

Both Eli Lilly and Novo Nordisk beat second-quarter estimates and raised their full-year outlooks. B

Bank of America spends over $250 million yearly on GLP-1 drugs, with CEO Brian Moynihan calling it a

Kathy Hochul says Trump's Medicare subsidy decision will raise prescription drug costs for 1.3 m

The CNN Money Fear and Greed index showed improvement in market sentiment on Wednesday, while Dow Jo

Eli Lilly remains a buy after Q2, with robust revenue growth and strong performance from Mounjaro an

As investors look to balance growth opportunities with defensive positioning, Acadia Pharmaceuticals

Sales of Mounjaro and Zepbound soared in the second quarter. Management lifted its full-year revenue

Eli Lilly and Company (LLY) Q2 2026 Earnings Call Transcript

CNBC Business News Update with Peter Schacknow - Markets & Business News With Expert Analysis From T

A few sectors have dominated the market this year, and healthcare isn't one of them. Many stocks in

Eli Lilly (NYSE:LLY | LLY Price Prediction) opened Wednesday's session with a blowout second-quarter

Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool

Extreme Positive Sentiment Please click here for an enlarged chart of SPDR S&P 500 ETF Tr

As of 11:50 AM ET, the Dow Jones Industrial Average (^DJI +0.83%) is up 0.80% to 54,521, and the S&P

Matt Tuttle can't quite pronounce the name of Eli Lilly's (LLY) oral weight-loss drug, but that does

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling over 100 points o

Stocks mixed as Nasdaq falls 100 points, Dow rises .79%. Eli Lilly beats earnings estimates, Digital

Today's ADP private-sector payrolls came in below the +75K forecast and less than half the downwardl

The headline numbers for Lilly (LLY) give insight into how the company performed in the quarter ende

Eli Lilly and Co (NYSE:LLY) shares rose nearly 7% in early trading Wednesday after the drugmaker rep

Eli Lilly (LLY) came out with quarterly earnings of $8.38 per share, beating the Zacks Consensus Est

Eli Lilly hikes its full-year guidance after earnings handily beat analysts' forecasts.

Eli Lilly reported second-quarter earnings and revenue that easily beat estimates and hiked its full

Revenue in Q2 2026 increased 48% to $23.0 billion driven primarily by Mounjaro and Zepbound volume.

CVS Pharmacy offers all FDA approved GLP-1s, whether through insurance or cash-pay options.New colla

Polymarket traders see more upside after the S&P 500 hit a record high on strong earnings and ho

BDF Gestion lowered its position in shares of Eli Lilly and Company (NYSE: LLY) by 3.6% in the secon

Market sentiment improves, Dow Jones jumps 900 points to record high. Crude oil prices fall on poten

Earnings are set to hit the tape in a tight window on Wednesday and the options market is already sk

Earnings coming Wed with varying volatility levels. Benzinga Pro selected list incl. relatively mute

HIGHLIGHTS Amplia has executed a Clinical Trial Collaboration & Supply Agreement (CTCSA) with Eli Li

Eli Lilly and Company (NYSE:LLY) will release its second-quarter earnings report before the opening

Despite its relatively modest gains this year, Eli Lilly is still one of the most widely followed ph

Eli Lilly is scheduled to report earnings Wednesday morning, with traders expecting the drugmaker's

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Earnings season is approaching, and Benzinga Pro has a list of top stocks to watch. Gilead Sciences